# Assessing the Efficacy and Safety of Photobiomodulation for the Treatment of Pruritus

> **NCT07450716** · EARLY_PHASE1 · NOT_YET_RECRUITING · sponsor: **Massachusetts General Hospital** · enrollment: 20 (estimated)

## Conditions studied

- Pruritus

## Interventions

- **DEVICE:** Light-emitting diode (LED) Photobiomodulation (PBM) device
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT07450716
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-04
- **Primary completion:** 2026-12
- **Final completion:** 2026-12
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2026-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07450716

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07450716, "Assessing the Efficacy and Safety of Photobiomodulation for the Treatment of Pruritus". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT07450716. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*